Maxillofacial surgery. 00
Conditions
Interventions
Intervention 1: Patients in the interventional group (first group) will be received an intravenous "Thiamine hydrochloride" 200 mg dissolved in Dextrose Water 5% via pump infusion bolus for 15 min. I
Treatment - Drugs
Patients in the interventional group (first group) will be received an intravenous "Thiamine hydrochloride" 200 mg dissolved in Dextrose Water 5% via pump infusion bolus for 15 min.
Patients in the the second group will receive " placebo" as same bolus volume of " Dextrose Water 5% " in a 15-minute intravenous infusion.
Sponsors
Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included: The patients with systemic disease and no history of drug use, and willingness to cooperate in this study are enrolled? Exclusion criteria included known allergy to the study drug, hepatic and renal dysfunction and lack of signed informed consent will be excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of postoperative pain. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: VAS.;Use of narcotic after surgery. Timepoint: To 12 hours after surgery. Method of measurement: Nursing reports. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-operative complications of Thiamine. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: Nursing reports.;Patient's level of satisfaction. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: poor (0), moderate (1), good (2), and excellent (3). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Reza Eftekharian
Shiraz Chamran Hospital
Outcome results
None listed